Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform-Reference-Cited by-同舟云学术

Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

Published:2021-01 Issue:2 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Shenoy Gautam N¹^ORCID,Greene Christopher J¹,Bhatta Maulasri²^ORCID,Baroja Miren L³,Loyall Jenni L¹,Balu‐Iyer Sathy V⁴,Kelleher Raymond J¹,Carreno Beatriz M³,Linette Gerald P³,Shultz Leonard D⁵,Bankert Richard B¹

Affiliation:

1. Department of Microbiology and Immunology at the Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo NY USA

2. Immune Modulatory Therapies, LLC Eden NY USA

3. Center for Cellular Immunotherapies Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

4. Department of Pharmaceutical Sciences University at Buffalo Buffalo NY USA

5. The Jackson Laboratory Bar Harbor ME USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1246

Reference43 articles.

1. Advances in cancer immunotherapy 2019 – latest trends

2. Finding the tumor copycat: Therapy fails, patients don't

3. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

4. Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency;Reddy S;Cancer Res,1987

5. Humanized mice for immune system investigation: progress, promise and challenges

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor Activities of Interleukin-12 in Melanoma;Cancers;2022-11-14

2. Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model;PLOS ONE;2022-09-12

3. Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments;Cells;2021-11-13

4. Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments;Journal for ImmunoTherapy of Cancer;2021-10